We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment.
- Authors
Pandey, K; Singh, D; Lal, C S; Das, V N R; Das, P
- Abstract
Pancreatitis is a known side effect of the once commonly used drug, sodium stibogluconate, for treatment of visceral leishmaniasis (VL). In India, miltefosine has recently been introduced as the first-line drug. Its side effects include loose motions, vomiting, and teratogenicity. We report here a case of a 41-year-old parasitologically confirmed male case of VL, who developed acute pancreatitis during treatment with miltefosine. On the 13 th day of treatment, he presented with abdominal pain and vomiting. The biochemical, hematological, and radiological features were suggestive of acute pancreatitis. The patient was put on conservative treatment for pancreatitis at the specialized center but succumbed to renal failure and septicaemia.
- Publication
Journal of postgraduate medicine, 2013, Vol 59, Issue 4, p306
- ISSN
0972-2823
- Publication type
Journal Article
- DOI
10.4103/0022-3859.123161